Nevro Corp Executives

NVRODelisted Stock  USD 5.84  0.00  0.00%   
Nevro Corp employs about 1.1 K people. The company is managed by 33 executives with a total tenure of roughly 161 years, averaging almost 4.0 years of service per executive, having 33.3 employees per reported executive. Analysis of Nevro Corp's management performance can provide insight into the firm performance.
DKeith Grossman  Chairman
Chairman of the Board, President, Chief Executive Officer
Christopher Christoforou  President
Vice President - Research and Development
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Nevro Corp Management Team Effectiveness

The company has return on total asset (ROA) of (0.0995) % which means that it has lost $0.0995 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4329) %, meaning that it created substantial loss on money invested by shareholders. Nevro Corp's management efficiency ratios could be used to measure how well Nevro Corp manages its routine affairs as well as how well it operates its assets and liabilities.
The majority of Nevro Corp outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Nevro Corp to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Nevro Corp. Please pay attention to any change in the institutional holdings of Nevro Corp as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Nevro Corp in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Nevro Corp, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Nevro Corp Workforce Comparison

Nevro Corp is regarded second in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 5,799. Nevro Corp retains roughly 1,099 in number of employees claiming about 19% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.22) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.22.

Nevro Corp Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nevro Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nevro Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nevro Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nevro Corp Notable Stakeholders

A Nevro Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nevro Corp often face trade-offs trying to please all of them. Nevro Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nevro Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kevin ThornalCEO PresidentProfile
DKeith GrossmanChairman of the Board, President, Chief Executive OfficerProfile
D GrossmanChairman of the Board, President, Chief Executive OfficerProfile
Christopher ChristoforouVice President - Research and DevelopmentProfile
Patrick SchmitzVice President - OperationsProfile
Roderick MacLeodChief Financial OfficerProfile
Elizabeth WeathermanIndependent DirectorProfile
Brad ValeIndependent DirectorProfile
Kevin OBoyleIndependent DirectorProfile
Shawn McCormickIndependent DirectorProfile
Frank FischerIndependent DirectorProfile
Michael DeManeLead Independent DirectorProfile
Susan SiegelIndependent DirectorProfile
Peter SocarrasGeneral VPProfile
Geeta KavetiVP OfficerProfile
Julie DeweyVice President - Investor Relations and Corporate CommunicationsProfile
Donald MiddlebrookVice President - Clinical, Regulatory and QualityProfile
Meredith VornholtVice MarketingProfile
Kashif JDSenior OfficerProfile
David CarawayChief Medical OfficerProfile
Christofer ChristoforouSenior OperationsProfile
Richard CarterChief OfficerProfile
Sridhar KosarajuDirectorProfile
Greg SillerSenior OfficerProfile
Shana MBASenior OfficerProfile
Michael CarterVice President - Global SalesProfile
Karen PrangeIndependent DirectorProfile
Angeline McCabeVice CommunicationsProfile
Kashif RashidChief Compliance Officer, General Counsel, Corporate SecretaryProfile
Niamh PellegriniChief Commercial OfficerProfile
Lori CianoChief Human Resource OfficerProfile
David MDSenior OfficerProfile
Jon ShearSenior DevelopmentProfile
String symbol = request.getParameter("s");

About Nevro Corp Management Performance

The success or failure of an entity such as Nevro Corp often depends on how effective the management is. Nevro Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nevro management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nevro management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California. Nevro Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 945 people.

Nevro Corp Workforce Analysis

Traditionally, organizations such as Nevro Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nevro Corp within its industry.

Nevro Corp Manpower Efficiency

Return on Nevro Corp Manpower

Revenue Per Employee371.7K
Revenue Per Executive12.4M
Net Loss Per Employee103.2K
Net Loss Per Executive3.4M
Working Capital Per Employee339.5K
Working Capital Per Executive11.3M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Nevro Stock

If you are still planning to invest in Nevro Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nevro Corp's history and understand the potential risks before investing.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Correlations
Find global opportunities by holding instruments from different markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.